{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:51:29Z","timestamp":1760550689138,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK067872","DK093406"],"award-info":[{"award-number":["DK067872","DK093406"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX002129"],"award-info":[{"award-number":["BX002129"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Magn Reson Mater Phy"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10334-018-0713-9","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T05:23:55Z","timestamp":1541049835000},"page":"163-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A 19F magnetic resonance imaging-based diagnostic test for bile acid diarrhea"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-4382","authenticated-orcid":false,"given":"Jean-Pierre","family":"Raufman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Metry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Felton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunrong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Polli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"713_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/bmb\/ldp032","volume":"92","author":"S Pattni","year":"2009","unstructured":"Pattni S, Walters JR (2009) Recent advances in the understanding of bile acid malabsorption. Br Med Bull 92:79\u201393. https:\/\/doi.org\/10.1093\/bmb\/ldp032","journal-title":"Br Med Bull"},{"issue":"11","key":"713_CR2","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cgh.2009.04.024","volume":"7","author":"JR Walters","year":"2009","unstructured":"Walters JR, Tasleem AM, Omer OS, Brydon WG, Dew T, le Roux CW (2009) A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol 7(11):1189\u20131194. https:\/\/doi.org\/10.1016\/j.cgh.2009.04.024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"713_CR3","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1111\/j.1572-0241.2007.01438.x","volume":"102","author":"F Fernandez-Banares","year":"2007","unstructured":"Fernandez-Banares F, Esteve M, Salas A, Alsina M, Farre C, Gonzalez C, Buxeda M, Forne M, Rosinach M, Espinos JC, Maria Viver J (2007) Systematic evaluation of the causes of chronic watery diarrhea with functional characteristics. Am J Gastroenterol 102(11):2520\u20132528. https:\/\/doi.org\/10.1111\/j.1572-0241.2007.01438.x","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"713_CR4","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","volume":"10","author":"RM Lovell","year":"2012","unstructured":"Lovell RM, Ford AC (2012) Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 10(7):712\u2013721. https:\/\/doi.org\/10.1016\/j.cgh.2012.02.029","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"713_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12955-017-0611-2","volume":"15","author":"JL Buono","year":"2017","unstructured":"Buono JL, Carson RT, Flores NM (2017) Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes 15(1):35. https:\/\/doi.org\/10.1186\/s12955-017-0611-2","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"713_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/mc.20253","volume":"46","author":"C Flynn","year":"2007","unstructured":"Flynn C, Montrose DC, Swank DL, Nakanishi M, Ilsley JN, Rosenberg DW (2007) Deoxycholic acid promotes the growth of colonic aberrant crypt foci. Mol Carcinog 46(1):60\u201370","journal-title":"Mol Carcinog"},{"issue":"8","key":"713_CR7","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00204-011-0648-7","volume":"85","author":"C Bernstein","year":"2011","unstructured":"Bernstein C, Holubec H, Bhattacharyya AK, Nguyen H, Payne CM, Zaitlin B, Bernstein H (2011) Carcinogenicity of deoxycholate, a secondary bile acid. Arch Toxicol 85(8):863\u2013871. https:\/\/doi.org\/10.1007\/s00204-011-0648-7","journal-title":"Arch Toxicol"},{"issue":"39","key":"713_CR8","doi-asserted-by":"publisher","first-page":"25572","DOI":"10.18632\/oncotarget.25385","volume":"9","author":"K Cheng","year":"2018","unstructured":"Cheng K, Metry M, Felton J, Shang AC, Drachenberg CB, Xu S, Zhan M, Schumacher J, Guo GL, Polli JE, Raufman JP (2018) Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice. Oncotarget 9(39):25572\u201325585. https:\/\/doi.org\/10.18632\/oncotarget.25385","journal-title":"Oncotarget"},{"issue":"10","key":"713_CR9","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1093\/carcin\/bgv107","volume":"36","author":"JP Raufman","year":"2015","unstructured":"Raufman JP, Dawson PA, Rao A, Drachenberg CB, Heath J, Shang AC, Hu S, Zhan M, Polli JE, Cheng K (2015) Slc10a2-null mice uncover colon cancer-promoting actions of endogenous fecal bile acids. Carcinogenesis 36(10):1193\u20131200. https:\/\/doi.org\/10.1093\/carcin\/bgv107","journal-title":"Carcinogenesis"},{"issue":"5","key":"713_CR10","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1021\/mp900163d","volume":"6","author":"X Zheng","year":"2009","unstructured":"Zheng X, Ekins S, Raufman JP, Polli JE (2009) Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter. Mol Pharm 6(5):1591\u20131603. https:\/\/doi.org\/10.1021\/mp900163d","journal-title":"Mol Pharm"},{"issue":"10","key":"713_CR11","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1080\/003655201750422693","volume":"36","author":"M Montagnani","year":"2001","unstructured":"Montagnani M, Love MW, Rossel P, Dawson PA, Qvist P (2001) Absence of dysfunctional ileal sodium-bile acid cotransporter gene mutations in patients with adult-onset idiopathic bile acid malabsorption. Scand J Gastroenterol 36(10):1077\u20131080","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"713_CR12","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/hep.29516","volume":"68","author":"M Sultan","year":"2018","unstructured":"Sultan M, Rao A, Elpeleg O, Vaz FM, Abu-Libdeh B, Karpen SJ, Dawson PA (2018) Organic solute transporter-beta (SLC51B) deficiency in two brothers with congenital diarrhea and features of cholestasis. Hepatology 68(2):590\u2013598. https:\/\/doi.org\/10.1002\/hep.29516","journal-title":"Hepatology"},{"issue":"11","key":"713_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cgh.2009.07.026","volume":"7","author":"AF Hofmann","year":"2009","unstructured":"Hofmann AF, Mangelsdorf DJ, Kliewer SA (2009) Chronic diarrhea due to excessive bile acid synthesis and not defective ileal transport: a new syndrome of defective fibroblast growth factor 19 release. Clin Gastroenterol Hepatol 7(11):1151\u20131154. https:\/\/doi.org\/10.1016\/j.cgh.2009.07.026","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"713_CR14","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/nm1501","volume":"12","author":"M Choi","year":"2006","unstructured":"Choi M, Moschetta A, Bookout AL, Peng L, Umetani M, Holmstrom SR, Suino-Powell K, Xu HE, Richardson JA, Gerard RD, Mangelsdorf DJ, Kliewer SA (2006) Identification of a hormonal basis for gallbladder filling. Nat Med 12(11):1253\u20131255. https:\/\/doi.org\/10.1038\/nm1501","journal-title":"Nat Med"},{"issue":"8","key":"713_CR15","first-page":"720","volume":"22","author":"GS Boyd","year":"1981","unstructured":"Boyd GS, Merrick MV, Monks R, Thomas IL (1981) Se-75-labeled bile acid analogs, new radiopharmaceuticals for investigating the enterohepatic circulation. J Nucl Med 22(8):720\u2013725","journal-title":"J Nucl Med"},{"issue":"5","key":"713_CR16","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1053\/j.gastro.2014.09.001","volume":"147","author":"DS Weinberg","year":"2014","unstructured":"Weinberg DS, Smalley W, Heidelbaugh JJ, Sultan S, Amercian Gastroenterological A (2014) American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome. Gastroenterology 147(5):1146\u20131148. https:\/\/doi.org\/10.1053\/j.gastro.2014.09.001","journal-title":"Gastroenterology"},{"key":"713_CR17","unstructured":"Wald A (2018) Treatment of irritable bowel syndrome in adults. UpToDate https:\/\/www.uptodate.com\/contents\/treatment-of-irritable-bowel-syndrome-in-adults . Accessed 30 Oct 2018"},{"issue":"10","key":"713_CR18","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.cgh.2013.04.029","volume":"11","author":"P Vijayvargiya","year":"2013","unstructured":"Vijayvargiya P, Camilleri M, Shin A, Saenger A (2013) Methods for diagnosis of bile acid malabsorption in clinical practice. Clin Gastroenterol Hepatol 11(10):1232\u20131239. https:\/\/doi.org\/10.1016\/j.cgh.2013.04.029","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"713_CR19","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/apt.14214","volume":"46","author":"P Vijayvargiya","year":"2017","unstructured":"Vijayvargiya P, Camilleri M, Carlson P, Lueke A, O\u2019Neill J, Burton D, Busciglio I, Donato L (2017) Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther 46(6):581\u2013588. https:\/\/doi.org\/10.1111\/apt.14214","journal-title":"Aliment Pharmacol Ther"},{"key":"713_CR20","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1038\/ctg.2012.10","volume":"3","author":"SS Pattni","year":"2012","unstructured":"Pattni SS, Brydon WG, Dew T, Walters JR (2012) Fibroblast growth factor 19 and 7alpha-hydroxy-4-cholesten-3-one in the diagnosis of patients with possible bile acid diarrhea. Clin Transl Gastroenterol 3:e18. https:\/\/doi.org\/10.1038\/ctg.2012.10","journal-title":"Clin Transl Gastroenterol"},{"issue":"3","key":"713_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1021\/mp0600135","volume":"3","author":"A Balakrishnan","year":"2006","unstructured":"Balakrishnan A, Wring SA, Coop A, Polli JE (2006) Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter. Mol Pharm 3(3):282\u2013292. https:\/\/doi.org\/10.1021\/mp0600135","journal-title":"Mol Pharm"},{"issue":"7","key":"713_CR22","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s11095-006-0219-4","volume":"23","author":"A Balakrishnan","year":"2006","unstructured":"Balakrishnan A, Wring SA, Polli JE (2006) Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation. Pharm Res 23(7):1451\u20131459. https:\/\/doi.org\/10.1007\/s11095-006-0219-4","journal-title":"Pharm Res"},{"issue":"11","key":"713_CR23","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.1002\/jps.24131","volume":"103","author":"D Vivian","year":"2014","unstructured":"Vivian D, Cheng K, Khurana S, Xu S, Dawson PA, Raufman JP, Polli JE (2014) Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging. J Pharm Sci 103(11):3782\u20133792. https:\/\/doi.org\/10.1002\/jps.24131","journal-title":"J Pharm Sci"},{"issue":"24","key":"713_CR24","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1016\/S0021-9258(17)42510-5","volume":"259","author":"AK Batta","year":"1984","unstructured":"Batta AK, Salen G, Shefer S (1984) Substrate specificity of cholylglycine hydrolase for the hydrolysis of bile acid conjugates. J Biol Chem 259(24):15035\u201315039","journal-title":"J Biol Chem"},{"key":"713_CR25","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.8b00454","author":"M Metry","year":"2018","unstructured":"Metry M, Felton J, Cheng K, Xu S, Ai Y, Xue F, Raufman JP, Polli J (2018) Attenuated accumulation of novel fluorine (19F)-labeled bile acid analogues in gallbladders of fibroblast growth factor-15 (FGF15)-deficient mice. Mol Pharm. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00454","journal-title":"Mol Pharm"},{"issue":"5","key":"713_CR26","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1124\/dmd.110.037358","volume":"39","author":"JP Raufman","year":"2011","unstructured":"Raufman JP, Xu S, Cheng K, Khurana S, Johnson D, Shao C, Kane MA, Shi D, Gullapalli R, Polli J (2011) In vivo magnetic resonance imaging to detect biliary excretion of 19F-labeled drug in mice. Drug Metab Dispos 39(5):736\u2013739. https:\/\/doi.org\/10.1124\/dmd.110.037358","journal-title":"Drug Metab Dispos"},{"key":"713_CR27","doi-asserted-by":"publisher","DOI":"10.3791\/54597","author":"J Felton","year":"2016","unstructured":"Felton J, Cheng K, Said A, Shang AC, Xu S, Vivian D, Metry M, Polli JE, Polli JE, Raufman JP (2016) Using multi-fluorinated bile acids and in vivo magnetic resonance imaging to measure bile acid transport. J Vis Exp. https:\/\/doi.org\/10.3791\/54597","journal-title":"J Vis Exp"},{"issue":"5","key":"713_CR28","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1021\/mp400740c","volume":"11","author":"D Vivian","year":"2014","unstructured":"Vivian D, Cheng K, Khurana S, Xu S, Kriel EH, Dawson PA, Raufman JP, Polli JE (2014) In vivo performance of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transport. Mol Pharm 11(5):1575\u20131582. https:\/\/doi.org\/10.1021\/mp400740c","journal-title":"Mol Pharm"},{"issue":"5","key":"713_CR29","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1007\/s11095-012-0963-6","volume":"30","author":"D Vivian","year":"2013","unstructured":"Vivian D, Cheng K, Khurana S, Xu S, Whiterock V, Witter D, Lentz KA, Santone KS, Raufman JP, Polli JE (2013) Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile acid transporter activity. Pharm Res 30(5):1240\u20131251. https:\/\/doi.org\/10.1007\/s11095-012-0963-6","journal-title":"Pharm Res"},{"issue":"4","key":"713_CR30","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","volume":"2","author":"T Inagaki","year":"2005","unstructured":"Inagaki T, Choi M, Moschetta A, Peng L, Cummins CL, McDonald JG, Luo G, Jones SA, Goodwin B, Richardson JA, Gerard RD, Repa JJ, Mangelsdorf DJ, Kliewer SA (2005) Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2(4):217\u2013225. https:\/\/doi.org\/10.1016\/j.cmet.2005.09.001","journal-title":"Cell Metab"},{"issue":"36","key":"713_CR31","doi-asserted-by":"publisher","first-page":"33920","DOI":"10.1074\/jbc.M306370200","volume":"278","author":"PA Dawson","year":"2003","unstructured":"Dawson PA, Haywood J, Craddock AL, Wilson M, Tietjen M, Kluckman K, Maeda N, Parks JS (2003) Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. J Biol Chem 278(36):33920\u201333927","journal-title":"J Biol Chem"},{"issue":"4","key":"713_CR32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jcmgh.2018.01.006","volume":"5","author":"CB Ferrebee","year":"2018","unstructured":"Ferrebee CB, Li J, Haywood J, Pachura K, Robinson BS, Hinrichs BH, Jones RM, Rao A, Dawson PA (2018) Organic solute transporter \u03b1-\u03b2 protects ileal enterocytes from bile acid-induced injury. Cell Mol Gastroenterol Hepatol 5(4):499\u2013522","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"8","key":"713_CR33","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/apt.12466","volume":"38","author":"SS Pattni","year":"2013","unstructured":"Pattni SS, Brydon WG, Dew T, Johnston IM, Nolan JD, Srinivas M, Basumani P, Bardhan KD, Walters JR (2013) Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. Aliment Pharmacol Ther 38(8):967\u2013976. https:\/\/doi.org\/10.1111\/apt.12466","journal-title":"Aliment Pharmacol Ther"},{"key":"713_CR34","doi-asserted-by":"crossref","first-page":"25572","DOI":"10.18632\/oncotarget.25385","volume":"9","author":"K Cheng","year":"2018","unstructured":"Cheng K, Metry M, Felton J, Shang AC, Drachenberg CB, Xu S, Zhan M, Schumacher J, Guo GL, Polli JE, Raufman J-P (2018) Diminished gallbladder filling, increased fecal bile acids, and promotion of colon epithelial cell proliferation and neoplasia in fibroblast growth factor 15-deficient mice. Oncotarget 9:25572\u201325585","journal-title":"Oncotarget"}],"container-title":["Magnetic Resonance Materials in Physics, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10334-018-0713-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10334-018-0713-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10334-018-0713-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:44:09Z","timestamp":1662338649000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10334-018-0713-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["713"],"URL":"https:\/\/doi.org\/10.1007\/s10334-018-0713-9","relation":{},"ISSN":["0968-5243","1352-8661"],"issn-type":[{"type":"print","value":"0968-5243"},{"type":"electronic","value":"1352-8661"}],"subject":[],"published":{"date-parts":[[2018,11,1]]},"assertion":[{"value":"30 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Drs. Polli and Raufman are recipients of United States patent 9,597,417, \u2018Compositions and methods to evaluate hepatobiliary\/gastrointestinal health, enterohepatic circulation, and drug interactions\u2019.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}